Bellicum Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing first-in-class cellular immunotherapies for hematological cancers and solid tumors.
Moleculin Biotech, Inc. is a pharmaceutical company focused on the development of anti-cancer drug candidates.
Marker Therapeutics (formerly known as TapImmune) develops immunotherapeutics to treat cancers, infectious diseases, autoimmune disorders, and transplant tissue rejection.
Aravive Biologics is a clinical stage biotechnology company formed as a result of a reverse merger between Versartis and Aravive.
Burzynski Research Institute is primarily engaged as a research and development facility for Antineoplaston drugs being tested for the use in the treatment of cancer.
Repros Therapeutics is a biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders.
InGeneron is elevating the field of regenerative medicine by translating robust science into proven patient benefit.
Solugen has developed a process for the synthesis of hydrogen peroxide inspired by principles of cancer biology.
PLx Pharma develops and commercializes non-steroidal anti-inflammatory drugs for prescription and over-the-counter markets.
OncoResponse is an immuno-oncology company.
Pulmotect is a biopharmaceutical company providing products for patients at risk of severe respiratory diseases.
MultiVir is a clinical-stage, immune-oncology company developing cancer treatments based on multiple gene therapy technologies.